フォローフィードコミュニティでトレーダーや投資家とつながりましょう.
包括的なオプション データを調査し、オプション フローで高度なフィルターを使用します.
ターミナル モニターで株式と資産のウォッチリストを整理および監視します
...
Theracryf PLC 19 February 2025 THIS ANNOUNCEMENT, INCLUDING THE APPENDIX, AND THE INFORMATION CONTAINED HEREIN IS RESTRICTED AND NOT FOR...
Theracryf PLC 19 February 2025 TheraCryf plc ("TheraCryf", the "Company" or the "Group") Experienced life sciences executive, Dr Alastair...
TheraCryf PLC said on Thusday its half-year pretax loss narrowed as it advanced drug development programmes in oncolo ...
Theracryf PLC 28 November 2024 TheraCryf plc ("TheraCryf" or "the Company" or "the Group") Half Year Report to 30 September 2024 ...
TheraCryf PLC on Wednesday confirmed it had been awarded a Composition of Matter patent in Europe for a new drug trea ...
Theracryf PLC 15 November 2024 TR-1: Standard form for notification of major holdings 1. Issuer Details ISIN GB00BSVYN304 Issuer Name...
Theracryf PLC 14 November 2024 TheraCryf plc ("TheraCryf", the "Company" or the "Group") Issue of Equity and Total Voting Rights Alderley...
Theracryf PLC 14 November 2024 TheraCryf plc ("TheraCryf", the "Company" or the "Group") Notice of Interim results and Presentation via...
The following is a round-up of London-listed company director and manager changes announced on Friday and Monday and ...
Theracryf PLC 04 November 2024 TheraCryf plc ("TheraCryf", the "Company" or the "Group") Passing of Dr Sue Foden, Chair Alderley Park, UK...
Theracryf PLC 29 August 2024 TheraCryf plc ("TheraCryf", the "Company" or the "Group") Grant of Options, Surrender of Existing Options and...
Theracryf PLC 08 August 2024 TR-1: Standard form for notification of major holdings 1. Issuer Details ISIN GB00BSVYN304 Issuer Name THERACRYF...
Support
ご覧いただいた銘柄が下記のボックス内に表示されますので、過去閲覧した銘柄情報に簡単にアクセスすることができます。
顧客サポート: +44 (0) 203 8794 460 | support@advfn.com
ADVFNのサービスをご利用いただくには、利用規約
サインアップして広告なしのエクスペリエンスを体験してください
今すぐ試してください
広告を残す